EUVIMEDEUVIMED entdecken
Crossref

Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment

Fariba Mohebichamkhorami, Mehrdad Faizi, Matin Mahmoudifard, Arman Hajikarim-Hamedani, Seyedeh Sarvenaz Mohseni, Amirhossein Heidari, Yekta Ghane, Mona Khoramjouy, Maryam Khayati, Rasoul Ghasemi, Hakimeh Zali, Simzar Hosseinzadeh und 1 weitere

Small · 2023-10 · 19 (40)

DOI: 10.1002/smll.202207626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 12.06.2023. Verfasst von Fariba Mohebichamkhorami und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Scienc…. Hauptthemen laut MEDLINE: Alzheimer Disease, Quantum Dots, Chitosan, Graphite. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: NIBIB NIH HHS, National Institute of Biomedical Imaging and Bioengineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles (NPs) based therapies for Alzheimer's disease (AD) attract interest due to their ability to pass across or bypass the blood‐brain barrier. Chitosan (CS) NPs or graphene quantum dots (GQDs) are promising drug carriers with excellent physicochemical and electrical properties. The current study proposes the combination of CS and GQDs in ultrasmall NP form not as drug carriers but as theranostic agents for AD. The microfluidic‐based synthesis of the CS/GQD NPs with optimized characteristics makes them ideal for transcellular transfer and brain targeting after intranasal (IN) delivery. The NPs have the ability to enter the cytoplasm of C6 glioma cells in vitro and show dose and time‐dependent effects on the viability of the cells. IN administration of the NPs to streptozotocin (STZ) induced AD‐like models lead to a significant number of entrances of the treated rats to the target arm in the radial arm water maze (RAWM) test. It shows the positive effect of the NPs on the memory recovery of the treated rats. The NPs are detectable in the brain via in vivo bioimaging due to GQDs as diagnostic markers. The noncytotoxic NPs localize in the myelinated axons of hippocampal neurons. They do not affect the clearance of amyloid β (A β ) plaques at intercellular space. Moreover, they showed no positive impact on the enhancement of MAP2 and NeuN expression as markers of neural regeneration. The memory improvement in treated AD rats may be due to neuroprotection via the anti‐inflammation effect and regulation of the brain tissue microenvironment that needs to be studied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseQuantum DotsChitosanGraphiteNanoparticlesRatsAnimalsAmyloid beta-PeptidesMicrofluidicsDrug Carriers

Stichwörter der Autor:innen

Alzheimer's treatmentbioimagingchitosangraphene quantum dotsmicrofluidicnanoparticles

Substanzen

ChitosanGraphiteAmyloid beta-PeptidesDrug Carriers

Autor:innen und Institutionen

  • Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1968917313, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, 19919-53381, Iran.
  • Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, 1497716316, Iran.
  • Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, 1916893813, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, 1461884513, Iran.
  • Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, 19919-53381, Iran.

ORCID-Profile: Ebrahim Mostafavi

Förderung

  • NIBIB NIH HHS
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Mohebichamkhorami, F., Faizi, M., Mahmoudifard, M., Hajikarim-Hamedani, A., Mohseni, S. S., Heidari, A., Ghane, Y., Khoramjouy, M., Khayati, M., Ghasemi, R., Zali, H., Hosseinzadeh, S., & Mostafavi, E. (2023). Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment. Small, 19(40). https://doi.org/10.1002/smll.202207626

Vancouver

Mohebichamkhorami F, Faizi M, Mahmoudifard M, Hajikarim-Hamedani A, Mohseni SS, Heidari A, et al. Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment. Small. 2023;19(40). doi:10.1002/smll.202207626

BibTeX
@article{Mohebichamkhorami2023,
  author = {Mohebichamkhorami, Fariba and Faizi, Mehrdad and Mahmoudifard, Matin and Hajikarim-Hamedani, Arman and Mohseni, Seyedeh Sarvenaz and Heidari, Amirhossein and Ghane, Yekta and Khoramjouy, Mona and Khayati, Maryam and Ghasemi, Rasoul and Zali, Hakimeh and Hosseinzadeh, Simzar and Mostafavi, Ebrahim},
  title = {Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment},
  journal = {Small},
  year = {2023},
  volume = {19},
  number = {40},
  doi = {10.1002/smll.202207626}
}
Kostenlos starten →